Analysts rate Aster DM Healthcare Limited Buy (bullish), based on 12 analysts. Average price target: ₹918.08.
Top signal score 22 of 100
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,836 of 26,280 companies
52.1
score / 100
Value
38
Quality
66
FCF yld0.3%
Earn yld0.7%
EV/EBITDA·
ROE10%
Gross mgn77%
Net mgn8.5%
Debt/EBITDA2.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
10,463 shares@ ₹155.10100.0% of flowEquity SharesSEBI:5ff13fba40c624636ac9382d6c9a7637b676418f
17 of 17 declarations
About Aster DM Healthcare Limited
Aster DM Healthcare Limited, an Indian Healthcare company listed on the Bombay Stock Exchange and valued at INR 566.7 billion, has 64.3% of its capital held by its 10 filers. The file contains almost no open-market operation: a single sale, without amount, 3 grants and 12 filings of another kind, among 16 filings published from June 18, 2021 to September 23, 2026.
Union Investments Private Limited filed 4, Union (Mauritius) Holdings Limited 3, Centella Mauritius Holdings Ltd 2, including the sale, and BCP Asia II Topco IV Pte. Ltd., registered as Promoter, one. Union (Mauritius) Holdings Limited also appears under the Promoter label, with one filing.
Read moreShow less
The split by year is: 3 filings in 2021, 2 in 2023, 2 in 2024, 4 in 2025 and 5 in 2026, the latter figure also being that of the last twelve months. The operations run from June 17, 2021 to September 23, 2026, and publication follows by a median of one day.